Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pneumopathies caused by Chlamydia pneumoniae].

J P Bruaire1, J P Ducroix, F Eb

  • 1Service de Médecine interne, Hôpital Nord, CHRU, Amiens.

Presse Medicale (Paris, France : 1983)
|June 20, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skin lesions.

La Revue de medecine interne·2023
Same author

Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome.

Autoimmunity·2019
Same author

Prevalence of anti-S100A10 antibodies in antiphospholipid syndrome patients.

Thrombosis research·2019
Same author

Interstitial lung disease in primary Sjögren's syndrome.

Autoimmunity reviews·2016
Same author

Antibodies directed against annexin A2 and obstetric morbidity.

Journal of reproductive immunology·2016
Same author

Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.

Lupus·2016

Chlamydia pneumoniae (TWAR strain) caused atypical pneumonia in six patients. Macrolide antibiotics effectively treated these infections, leading to complete recovery without complications.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Respiratory Medicine

Background:

  • Atypical pneumonias present diagnostic challenges.
  • Chlamydia pneumoniae (TWAR strain) is an identified cause of community-acquired pneumonia.
  • Early and accurate diagnosis is crucial for effective treatment.

Observation:

  • Six cases of atypical pneumonia were diagnosed as Chlamydia pneumoniae (TWAR strain) infection between March 1990 and March 1991.
  • Microimmunofluorescence testing confirmed high anti-TWAR antibody levels (>512) in affected patients.
  • Two additional patients with pneumonia symptoms could not be definitively diagnosed due to serological cross-reactivity.

Findings:

  • All six confirmed Chlamydia pneumoniae patients were successfully treated with oral macrolide antibiotics (roxithromycin, erythromycin, azithromycin).

Related Experiment Videos

  • Treatment resulted in complete cure without sequelae or recurrence.
  • The study highlights the efficacy of macrolides in treating TWAR strain pneumonia.

    • Implications:

    • Macrolide antibiotics are effective for treating Chlamydia pneumoniae (TWAR strain) pneumonia.
    • Accurate serological diagnosis is essential, but cross-reactivity can complicate interpretation.
    • Further research into diagnostic methods and treatment protocols for atypical pneumonias is warranted.